GL Pharm Tech Corp.

KOSDAQ:A204840 Stock Report

Market Cap: ₩78.0b

GL Pharm Tech Management

Management criteria checks 0/4

We currently do not have sufficient information about the CEO.

Key information

Hun-Sik Wang

Chief executive officer

n/a

Total compensation

CEO salary percentagen/a
CEO tenureno data
CEO ownershipn/a
Management average tenureno data
Board average tenureno data

Recent management updates

No updates

Recent updates

Is GL Pharm Tech (KOSDAQ:204840) A Risky Investment?

Jul 23
Is GL Pharm Tech (KOSDAQ:204840) A Risky Investment?

Market Participants Recognise GL Pharm Tech Corp.'s (KOSDAQ:204840) Revenues Pushing Shares 25% Higher

Mar 01
Market Participants Recognise GL Pharm Tech Corp.'s (KOSDAQ:204840) Revenues Pushing Shares 25% Higher

Would GL Pharm Tech (KOSDAQ:204840) Be Better Off With Less Debt?

Mar 30
Would GL Pharm Tech (KOSDAQ:204840) Be Better Off With Less Debt?

The GL Pharm Tech (KOSDAQ:204840) Share Price Is Up 50% And Shareholders Are Holding On

Dec 15
The GL Pharm Tech (KOSDAQ:204840) Share Price Is Up 50% And Shareholders Are Holding On

CEO

Hun-Sik Wang (53 yo)

no data

Tenure

Mr. Wang serves as the Chief Executive Officer of GL PharmTech Corp.